850 Maude Avenue
Mountain View, CA 94043
March 27, 2013
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-3
Filed March 20, 2013
File No. 333-187387
Ladies and Gentlemen:
Reference is made to the Registration Statement on Form S-3 (File No. 333-187387) filed with the Securities and Exchange Commission (the Commission) by ChemoCentryx, Inc. on March 20, 2013 (the Registration Statement). Pursuant to Rule 473(c) of the Securities Act of 1933, as amended (the Act), the following delaying amendment, prescribed by Rule 473(a) of the Act, is hereby incorporated onto the cover page of the Registration Statement immediately following the calculation of the registration fee:
The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.
If you have any questions or require additional information, please contact Michael Sullivan, Esq. of Latham & Watkins LLP at (858) 523-3959.
|Name:||Susan M. Kanaya|
|Title:||Senior Vice President, Finance, Chief|
|Financial Officer and Secretary|